Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
P.VolanteA
Collectively, these findings provide strong population-level evidence that periodontitis is not only a marker of oral health decline but also a contributor to systemic vascular risk, highlighting the need to integrate periodontal status into cardiovascular risk assessment
The compound failed its Phase IIb obesity endpoint in 2007, and Metabolic Pharmaceuticals terminated clinical development the same year
It is not a pharmaceutical product, dietary supplement, cosmetic, or food
And sometimes the most appropriate recommendation is to investigate the underlying problem further before making any treatment decision
